Literature DB >> 2565581

Somatostatin and its analogues in the therapy of gastrointestinal disease.

D Wynick1, J M Polak, S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2565581     DOI： 10.1016/0163-7258(89)90113-7

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  5 in total

Review 1.  Arterial embolization in the management of liver metastases.

Authors:  D J Allison; A Booth
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

2.  Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein.

Authors:  D Wynick; W A Ratcliffe; D A Heath; S Ball; M Barnard; S R Bloom
Journal:  BMJ       Date:  1990-05-19

3.  Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.

Authors:  T Kissel; J Drewe; S Bantle; A Rummelt; C Beglinger
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Effect of octreotide (Sandostatin 201-995) on bile flow and bile components.

Authors:  M Sahin; A Kartal; M Belviranli; S Yol; F Aksoy; M Ak
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Effects of the long-acting somatostatin analogue octreotide on abomasal function and plasma level of insulin and glucagon in sheep.

Authors:  K Holtenius
Journal:  Acta Vet Scand       Date:  1994       Impact factor: 1.695
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.